0141 352 98 55

25 Blythswood Square, Glasgow, G2 4BL

Investment pitch at #NOAH16
November 11, 2016
NOAH16

Scott opened with: “Global Medicines in Crisis”,$500 billion is wasted globally in suboptimal use of medicines at NOAH16 an investment pitch in London.

Dr Scott Crae MRCVS co-founder of Talking Medicines presented today to MedTech investors at NOAH16 opening with the statement “Global Medicines in Crisis”. $500 billion is wasted globally in suboptimal use of medicines.  With 50% of people on a prescription medicines at any time, this is an everyday problem.  He presented the fact that 50% of people on medicines are not taking them as directed by their healthcare professional. This combined with a stretched health system creates a key problem to address.

Talking Medicines have a big data analytics solution that pushes trusted information out to consumers about their medicines, initially via a mobile App, whilst collecting back real world data about how medicines are actually used for healthcare stakeholders to access via a customised data portal.  This enables all stakeholders to more effectively manage and understand medicines.
The consumer solution allows the consumer to be in control of their health, particularly when they are on multiple medicines. They can access interactive, audiovisual content about how medicines work and how best to take them.  They can load medicines into a single view, bookmark them & use smart reminders to take them.
This model is designed for Global markets starting with the UK.  The commercial, subscription, model is to allow access to the data portal for Pharma Co brand managers and R&D Managers on a per medicine basis, before rolling out to other stakeholders. Text mining and big data analytics play a fundamental role in processing data at an aggregate level to understand patterns of usage to make medicines more effective.
Jo Halliday and Elizabeth Fairley, Directors at Talking Medicines were pleased to be at NOAH16 with Scott & be able to talk directly with investors about creating European partners to rapidly gain global market share.
We look forward to the future ahead.

 

Recent Blogs

Appointment of Head of Data Quality

Appointment of Head of Data Quality

Data insights firm Talking Medicines, specialist in ‘social intelligence’ for the pharmaceutical industry, has appointed Donna Lawson to the position of Head of Data Quality. A particularly good fit for the role, Donna brings with her over two decades’ experience...

The effect of self-diagnosis on patient outcomes

The effect of self-diagnosis on patient outcomes

The internet is a wonderful place. You can find photos of places you want to visit, maps of your favourite mountain ranges, tutorials on how to bake the perfect birthday cake…the list goes on. In recent years, however, there has been a marked increase in the number of...

Pharma Business International Interview

Pharma Business International Interview

Pharma Business International spoke with Jo Halliday, CEO of Talking Medicines, the world’s first social intelligence company designed specifically for the pharmaceutical industry.  The full article can be found here on page 10-11 Tell us about Talking Medicines?...

Tracking Covid vaccine progress through Medsmart®

Tracking Covid vaccine progress through Medsmart®

In the race against new super spreading virus variants, the UK among other countries have implemented a fast streamed vaccine programme to protect the vulnerable as quickly as possible. Since the beginning of January, 17,916,181 people in the UK have been given their...